Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
for Obesity
71 locations incl. Birmingham
Sponsor: Gasherbrum Bio, Inc., a wholly owned subsidiary of Structure Therapeutics
Sex: All·Age: 18 - 79
Code: NCT07654361·Phase 3·Not Yet Recruiting·Listed Jun 17, 2026